Immucor Acquires Division of Biopool
TM Capital assisted Immucor, Inc. (NASDAQ) in the acquisition of the BCA division of Biopool International, Inc. (NASDAQ)
TM Capital assisted Immucor, Inc. (NASDAQ) in the acquisition of the BCA division of Biopool International, Inc. (NASDAQ)
TM Capital advised Epic Therapeutics in its acquisition by Baxter Healthcare Corporation (NYSE:BAX) subsequent to a collaboration agreement and investment by Baxter
TM Capital advised the Special Committee of the Board of B&G Foods (NYSE) on the recapitalization and repurchase of its Class B common stock in connection with its $208 million IPO of Class A common stock
TM Capital advised ECI Group, an integrated real estate company, on its $208 million recapitalization with AREA Property Partners, a leading international real estate fund manager
TM Capital advised Surpass Medical, Ltd. in its sale to Stryker Corporation (NYSE:SYK) for $135 million in cash and future consideration
TM Capital served as exclusive financial advisor to Starbucks Corporation (NASDAQ:SBUX) in its sale of the Puerto Rico Operations to Baristas Del Caribe, LLC, an affiliate of Empresas Fonalledas Inc.
TM Capital served as exclusive financial advisor to Ferrellgas Partners, L.P. in the sale of Blue Rhino Global Sourcing, Inc. to an undisclosed buyer
TM Capital served as exclusive financial advisor to Maxons Restorations, Inc. in connection with its sale to First Onsite Property Restoration, a subsidiary of FirstService Corporation (TSX: FSV)
TM Capital served as exclusive financial advisor to New Market Waste Solutions in its sale to Waste Harmonics
TM Capital served as exclusive financial advisor to T BAILEY, in connection with its sale to Saothair Capital Partners